Patient Pathfinder: Clinical Trials
Clinical Trials for Myelodysplastic Syndrome
Every life-saving or life-extending treatment that’s available today started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand Myelodysplastic Syndrome (MDS), and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 166 active Myelodysplastic Syndrome trials
Allogeneic Hematopoietic Stem Cell Transplantation With JSP191-Based Conditioning in Participants With GATA2 Deficiency
Study Type: Interventional Phase 2
JSP191 (Briquilimab) in Subjects With LR-MDS
Study Type: Interventional Phase 1
MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
Study Type: Interventional
Cord Blood Transplant in Adults With Blood Cancers
Study Type: Interventional Phase 2
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Study Type: Interventional Phase 1
MT2021-08T Cell Receptor Alpha/Beta Depletion PBSC Transplantation for Heme Malignancies
Study Type: Interventional Phase 2
Single Arm, Open Label Trial With Iptacopan Treatment for 24 Weeks, in Patients on Stable Regimen of Anti-C5 Who Switch to Iptacopan.
Study Type: Interventional Phase 3
There are 166 active Myelodysplastic Syndrome trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now